Buy or sell Evolve Biosystems stock pre IPO via an EquityZen fund
Evolve Biosystems Stock
Evolve BioSystems is developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.
About Evolve Biosystems Stock
Evolve Biosystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. The company builds on more than a decade of research into the infant biome and its intimate interaction with breast milk components established by the founding scientists including Bruce German, David Mills, Carlito Lebrilla, Daniela Barile and Samara Freeman. Their fundamental research and translational clinical trials have been enabled by more than $15 million in federal and private grants since 2004.
Director, IP & Regulatory Affairs
Global University Venturing - Jun, 14 2018
PE Hub (blog) - Jun, 13 2018
PR Newswire (press release) - Dec, 6 2017
Marketwired (press release) - Aug, 1 2017
Marketwired (press release) - May, 30 2017